Adaptive Biotechnologies Corporation is a commercial-stage company. The Company focuses on the field of immune medicine by harnessing the inherent biology of the adaptive immune s ...

Discover the captivating mystery of bioluminescent fungi. Explore how these glowing organisms light up forests, their unique ...

Paper2Agent, published in Nature on September 16 by Stanford researchers, converts static research papers into callable AI agents via MCP servers in 45 minutes for $14. The system validates tools ...

Even as U.S. officials this week awaited the arrival of a sample of the new bird flu virus from China - typically the first ...

This study presents valuable findings regarding the role of the P2X7 receptor in retinoic acid signaling-mediated retinal remodeling following photoreceptor degeneration. However, the evidence ...

Anthropic published a research post on September 17, 2026, reporting that Claude optimized more than 30 open-source ...

Founderof The LSM Group to support KALA's growth across its existing business and potential acquisitionsNEW YORK, Sept. 17, ...

Adaptive Biotechnologies Corporation Reports Q2 Revenue $71.6M, vs. FactSet Est of $65.4M MT Jul. 29 Adaptive Biotechnologies Corporation Reports Earnings Results for the Second Quarter and Six Months ...

According to AnthropicAI, Claude optimized 30+ bio models with GPU code, delivering 4x faster inference and open-sourced tools for broader impact.

CRISPR-Cas provides RNA-mediated adaptive immunity, but how its first RNA-guided effector arose is unclear. In this study, we report the discovery of Viral Interference Programmable Repeat (VIPR) ...

Researchers at Maynooth University just built a breakthrough DNA computer capable of math like addition, multiplication and ...

A new understanding of transfer RNA biology means researchers can assign up to 34 codons to amino acids of their choosing ...